Dario Giuffrida
Impact in
-
- Thyroid Cancer Diagnosis and Treatment
- Thyroid Disorders and Treatments
- Oncology top 2%
- Cancer-related Molecular Pathways
Papers in
-
- Thyroid Cancer Diagnosis and Treatment 32
- Oncology 41
- Lung Cancer Research Studies 10
- HER2/EGFR in Cancer Research 8
- Cancer Treatment and Pharmacology 7
- Co-authors
- Riccardo VigneriAntonino BelfioreHossein GharibH GharibSébastiano FilettiLorenzo LupoConcetto RegalbutoO Ippolito
- Journals
- Annals of Oncology (7 papers)The Journal of Clinical Endocrinology & Metabolism (5 papers)Journal of Clinical Oncology (5 papers)Cancers (4 papers)Lung Cancer (3 papers)
- Partner nations
- ItalyUnited StatesFrance
In The Last Decade
Dario Giuffrida
87 papers receiving 3.5k citations
Peers
Comparison fields: 5 of 119
- Endocrinology, Diabetes and Metabolism 2.2k
- Oncology 1.0k
- Cancer Research 452
- Surgery 1.1k
- Anatomy 29
Countries citing papers authored by Dario Giuffrida
This map shows the geographic impact of Dario Giuffrida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dario Giuffrida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dario Giuffrida more than expected).
Fields of papers citing papers by Dario Giuffrida
This network shows the impact of papers produced by Dario Giuffrida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dario Giuffrida. The network helps show where Dario Giuffrida may publish in the future.
Co-authors
The 25 scholars most cited alongside Dario Giuffrida, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 4 | |
| 4 | 2022 | 16 | |
| 5 | 2022 | 23 | |
| 6 | 2021 | 4 | |
| 7 | 2021 | 4 | |
| 8 | 2020 | 9 | |
| 9 | 2020 | 10 | |
| 10 | 2020 | 9 | |
| 11 | 2019 | 6 | |
| 12 | 2017 | 36 | |
| 13 | 2017 | 1 | |
| 14 | 2016 | 23 | |
| 15 | 2013 | 20 | |
| 16 | 2011 | 16 | |
| 17 | 2002 | 55 | |
| 18 | 2001 | 7 | |
| 19 | 1990 | 273 | |
| 20 | 1990 | 2 |
About Dario Giuffrida
Dario Giuffrida is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology, Cancer Research, Genetics and Pulmonary and Respiratory Medicine, having authored 94 papers that have together received 3.6k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (32 papers), Lung Cancer Treatments and Mutations (10 papers), Lung Cancer Research Studies (10 papers), Neuroendocrine Tumor Research Advances (8 papers), HER2/EGFR in Cancer Research (8 papers), Thyroid and Parathyroid Surgery (7 papers), Cancer Treatment and Pharmacology (7 papers) and BRCA gene mutations in cancer (6 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.2k citations), Oncology (1.0k citations), Cancer Research (452 citations), Surgery (1.1k citations) and Anatomy (29 citations). Dario Giuffrida has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Riccardo Vigneri, Antonino Belfiore, Hossein Gharib, H Gharib, Sébastiano Filetti, Lorenzo Lupo, Concetto Regalbuto, O Ippolito, Gabriella Pellegriti and Giovanni Milazzo. Their work appears in journals such as Annals of Oncology, The Journal of Clinical Endocrinology & Metabolism, Journal of Clinical Oncology, Cancers and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.